<DOC>
	<DOCNO>NCT02102633</DOCNO>
	<brief_summary>The study evaluate effect single oral dose bosutinib single dose pharmacokinetics dabigatran , p-glycoprotein substrate , healthy subject .</brief_summary>
	<brief_title>Drug Interaction Study Between Bosutinib And Dabigatran</brief_title>
	<detailed_description />
	<mesh_term>Dabigatran</mesh_term>
	<criteria>Healthy subject 21 55 year old BMI 17.5 30.5 kg/m2 . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Risks bleed include prior personal familiar history abnormal bleeding , hereditary acquire coagulation platelet disorder abnormal coagulation test ( PT/INR PTT/aPTT great upper limit normal ) result screen . Pregnant nursing female ; female childbearing potential unwilling unable use acceptable method nonhormonal contraception outline protocol least 14 day prior first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>bosutinib</keyword>
	<keyword>dabigatran</keyword>
	<keyword>drug interaction</keyword>
	<keyword>p-glycoprotein</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>